Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Mar 15, 2023; 15(3): 464-489
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.464
Published online Mar 15, 2023. doi: 10.4251/wjgo.v15.i3.464
Figure 4 Xiaojianzhong decoction up-regulates phosphatidylinositol 3-kimase/protein kinase B/mammalian target of rapamycin signaling pathway in N-methyl-N’-nitro-N-nitrosoguanidine-induced gastric precancerous lesions rats.
A-C: Western blot analysis was performed to detect phosphorylated-phosphatidylinositol 3-kimase (p-PI3K), phosphorylated-protein kinase B (p-AKT), and phosphorylated-mammalian target of rapamycin (p-mTOR) protein expression (n = 3); D-F: PI3K, AKT, and mTOR mRNA expression was determined using real-time polymerase chain reaction analysis (n = 3). Data are expressed as mean ± standard deviation. aP < 0.05, bP < 0.01, cP < 0.001 vs control group; dP < 0.05, eP < 0.01, fP < 0.001 vs model group. XJZ-L: Low dose of Xiaojianzhong decoction; XJZ-M: Middle dose of Xiaojianzhong decoction; XJZ-H: High dose of Xiaojianzhong decoction.
- Citation: Zhang JX, Bao SC, Chen J, Chen T, Wei HL, Zhou XY, Li JT, Yan SG. Xiaojianzhong decoction prevents gastric precancerous lesions in rats by inhibiting autophagy and glycolysis in gastric mucosal cells. World J Gastrointest Oncol 2023; 15(3): 464-489
- URL: https://www.wjgnet.com/1948-5204/full/v15/i3/464.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i3.464